Caspase-mediated apoptotic machinery

The caspase-mediated apoptotic machinery is a complex biochemical network of cysteine-aspartic proteases (caspases) that serves as the primary executioner of programmed cell death (StatPearls: Caspase Cascade). This machinery is organized into two main signaling branches: the intrinsic (mitochondrial) pathway and the extrinsic (death receptor) pathway (NIH: Molecular Biology of the Cell). The intrinsic pathway is regulated by the Bcl-2 family of proteins in response to internal cellular stress, while the extrinsic pathway is triggered by external ligands like TNF-alpha. Upon activation, initiator caspases (e.g., Caspase-8, Caspase-9) undergo proteolytic processing to activate executioner caspases (e.g., Caspase-3, Caspase-7). These executioner caspases then cleave a wide array of cellular substrates, leading to DNA fragmentation, membrane blebbing, and cell shrinkage (PubMed: PMC2117903). In oncology, many tumors develop resistance by upregulating anti-apoptotic proteins like Bcl-2, making this machinery a prime target for BH3 mimetics like Venetoclax (PubChem: CID 49846579). Conversely, in neurodegenerative and inflammatory diseases, excessive caspase activity leads to pathological cell loss, prompting the development of caspase inhibitors like Emricasan. However, clinical success for direct caspase inhibitors has been limited by safety concerns and the challenge of achieving tissue-specific inhibition (Nature Reviews Drug Discovery).

Other names

Caspase cascadeApoptotic signaling pathwayProgrammed cell death machineryCaspase-dependent apoptosis

Induction of apoptosis via Bcl-2 inhibition or direct inhibition of caspase proteolytic activity to prevent cell death.